Kevin T. Conroy - Insider Trading & Ownership

Location
5505 Endeavor Lane, Madison, WI
Summary
The estimated net worth of Kevin T. Conroy is at least $43.6M dollars as of September 25, 2025. Kevin T. Conroy is the President and CEO, Director of EXACT SCIENCES CORP and owns shares of EXACT SCIENCES CORP (EXAS) stock worth about $42.6M. Kevin T. Conroy is the Director of ALIGN TECHNOLOGY INC and owns shares of ALIGN TECHNOLOGY INC (ALGN) stock worth about $677K. Kevin T. Conroy is the Director of SomaLogic, Inc. and owns shares of SomaLogic, Inc. stock worth about $250K. Kevin T. Conroy is the Director of Adaptive Biotechnologies Corp and owns shares of Adaptive Biotechnologies Corp (ADPT) stock worth about $94.9K. Kevin T. Conroy is the Director of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $23K.
Signature
/s/ Jeffrey Vignos, as attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Kevin T. Conroy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EXAS EXACT SCIENCES CORP President and CEO, Director $42.6M +$1M +2.41% Mar 7, 2025
ALGN ALIGN TECHNOLOGY INC Director $677K May 21, 2025
SLGCW SomaLogic, Inc. Director $250K Sep 1, 2021
ADPT Adaptive Biotechnologies Corp Director $94.9K Mar 6, 2023
EPZM Epizyme, Inc. Director $23K Aug 12, 2022
AEXA American Exceptionalism Acquisition Corp. A Director Sep 25, 2025

Insider Transactions Reported by Kevin T. Conroy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.